Evaluation of Ginger (Zingiber Officinale Roscoe) on Energy Metabolism and Obesity: Systematic Review and Meta-Analysis

2019 ◽  
Vol 35 (7) ◽  
pp. 685-706
Author(s):  
Melahat Sedanur Macit ◽  
Saniye Sözlü ◽  
Betül Kocaadam ◽  
Nilüfer Acar-Tek
Cytokine ◽  
2020 ◽  
Vol 135 ◽  
pp. 155224 ◽  
Author(s):  
Mojgan Morvaridzadeh ◽  
Siavash Fazelian ◽  
Shahram Agah ◽  
Maryam Khazdouz ◽  
Mehran Rahimlou ◽  
...  

2016 ◽  
Vol 2016 ◽  
pp. 1-10 ◽  
Author(s):  
Chen X. Chen ◽  
Bruce Barrett ◽  
Kristine L. Kwekkeboom

This systematic review examines the efficacy of oral ginger for dysmenorrhea. Key biomedical databases and grey literature were searched. We included randomized controlled trials comparing oral ginger against placebo or active treatment in women with dysmenorrhea. Six trials were identified. Two authors independently reviewed the articles, extracted data, and assessed risk of bias. Discrepancies were resolved by consensus with a third reviewer. We completed a narrative synthesis of all six studies and exploratory meta-analyses of three studies comparing ginger with placebo and two studies comparing ginger with a nonsteroidal anti-inflammatory drug (NSAID). Ginger appeared more effective for reducing pain severity than placebo. The weighted mean difference on a 10 cm visual analogue scale was 1.55 cm (favoring ginger) (95% CI 0.68 to 2.43). No significant difference was found between ginger and mefenamic acid (an NSAID). The standardized mean difference was 0 (95% CI −0.40 to 0.41). Available data suggest that oral ginger could be an effective treatment for menstrual pain in dysmenorrhea. Findings, however, need to be interpreted with caution because of the small number of studies, poor methodological quality of the studies, and high heterogeneity across trials. The review highlights the need for future trials with high methodological quality.


2017 ◽  
Vol 32 (4) ◽  
pp. 577-585 ◽  
Author(s):  
Vahideh Ebrahimzadeh Attari ◽  
Aida Malek Mahdavi ◽  
Zeinab Javadivala ◽  
Sepideh Mahluji ◽  
Sepideh Zununi Vahed ◽  
...  

2021 ◽  
Vol 149 ◽  
pp. 105225
Author(s):  
Ayush Noori ◽  
Aziz M. Mezlini ◽  
Bradley T. Hyman ◽  
Alberto Serrano-Pozo ◽  
Sudeshna Das

2020 ◽  
Vol 4 (Supplement_2) ◽  
pp. 1-1
Author(s):  
Sepideh Alasvand ◽  
William Bridges ◽  
Vivian Haley-Zitlin

Abstract Objectives This systematic review and meta-analysis explored efficacy of common spices cardamom, ginger, cumin, curcuminoids and cinnamon on improving serum lipid levels in people with type 2 diabetes. Methods Databases PubMed, FSTA, Web of Science, CINAHEL, MEDLINE and Cochrane Library database of systematic review were searched using keywords (“Serum lipids” OR triglyceride* OR cholesterol* OR “LDL” OR “HDL” OR dyslipidemia) AND (Ginger or zingiber or “zingiber officinale” or “cinnamomum zeylanicum” or “cinnamomum aromaticum” or “cinnamomum cassia” or “cinnamomum verum” or curcumin or turmeric or curcuminoids or “curcuma longa” or langas or “curcuma zedoarias” or turmeric) AND (diabetes* OR “diabetes mellitus” OR “type 2” OR “blood glucose” OR insulin* OR antidiabet* OR "glucose level”) up to January 2020. Statistical calculations used SAS software version 9.2 (SAS, Cary NC, USA). Results Of 636 studies, 27 met the meta-analysis selection criteria, with 5698 trial participants total. The spices significantly improved TC, TG, and LDL-C, with no significant effect on HDL-C. The reduction in intervention vs. control was: TC, −5.0912 mg/dl, 95% CI (−18.7167, −0.7804), P value 0.038; TG, −9.7486 mg/dl, 95% CI (−33.9445, −5.8260), P value 0.33; LDL-C, −4.653 mg/dl, 95% CI (−8.686, −0.6212), P value 0.02. No significant effect on HDL-C was seen (−0.019 mg/dl, 95% CI (−0.72, 0.68), P = 0.95. Heterogeneity was observed across all 27 studies. Conclusions Spices examined exhibited a significant reduction in TG, TC and LDL-C levels among patients with type 2 diabetes with no effect on HDL-C levels suggesting a role for spices as a dyslipidemic agent. Funding Sources Clemson University.


2021 ◽  
Vol 45 (2) ◽  
Author(s):  
Mojgan Morvaridzadeh ◽  
Ehsan Sadeghi ◽  
Shahram Agah ◽  
Siavash Fazelian ◽  
Mehran Rahimlou ◽  
...  

2021 ◽  
Author(s):  
Yali Wei ◽  
Yan Meng ◽  
Na Li ◽  
Qian Wang ◽  
Liyong Chen

The purpose of the systematic review and meta-analysis was to determine if low-ratio n-6/n-3 long-chain polyunsaturated fatty acid (PUFA) supplementation affects serum inflammation markers based on current studies.


Sign in / Sign up

Export Citation Format

Share Document